Search Results | CW MARS

Catalog Search Results

Sort by

1) Hearing on removing Social Security numbers from Medicare cards: joint hearing before the Subcommittee on Social Security and Subcommittee on Health of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Twelfth...

Author

United States. Congress. House. Committee on Ways and Means. Subcommittee on Social Security

Publisher

U.S. Government Printing Office

Pub. Date

2013.

Language

English

2) Full committee hearing on competitive bidding for clinical lab services: where it is heading and what small businesses can expect

Author

United States. Congress. House. Committee on Small Business

Publisher

U.S. G.P.O

Pub. Date

2007

Language

English

3) Medicaid managed care encounter data: collection and use

Author

United States. Department of Health and Human Services. Office of Inspector General

Publisher

Department of Health and Human Services, Office of Inspector General

Pub. Date

2009.

Language

English

4) Oversight challenges in the Medicare prescription drug program: hearing before the Federal Financial Management, Government Information, Federal Services, and International Security Subcommittee of the Committee on Homeland Security and...

Author

United States. Congress. Senate. Committee on Homeland Security and Governmental Affairs. Subcommittee on Federal Financial Management, Government Information, Federal Services, and International Security

Series

S. hrg volume 111-727

Publisher

U.S. G.P.O

Pub. Date

2010.

Language

English

5) The use of data to stop Medicare fraud: hearing before the Subcommittee on Oversight of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Fourteenth Congress, first session, March 24, 2015

Author

United States. Congress. House. Committee on Ways and Means. Subcommittee on Oversight

Publisher

U.S. Government Publishing Office

Pub. Date

2016.

Language

English

6) Calculation of volume-weighted average sales price for Medicare Part B prescription drugs

Author

United States. Department of Health and Human Services. Office of Inspector General

Publisher

Department of Health and Human Services, Office of Inspector General

Pub. Date

2006.

Language

English

7) CMS's implementation of safeguards during fiscal year 2006 to prevent and detect fraud and abuse in Medicare prescription drug plans

Author

United States. Department of Health and Human Services. Office of Inspector General

Publisher

Department of Health and Human Services, Office of Inspector General

Pub. Date

2007.

Language

English

8) Medicare's program safeguard contractors: activities to detect and deter fraud and abuse

Author

United States. Department of Health and Human Services. Office of Inspector General

Publisher

Department of Health and Human Services, Office of Inspector General

Pub. Date

2007.

Language

English

9) Roundtable discussion on Medicare physician payment policy: lessons from the private sector : hearing before the Committee on Finance, United States Senate, One Hundred Twelfth Congress, second session, June 14, 2012

Author

United States. Congress. Senate. Committee on Finance

Series

S. hrg volume 112-777

Publisher

U.S. Government Printing Office

Pub. Date

2012.

Language

English

10) Omission of drugs from the federal upper limit list in 2001

Author

United States. Department of Health and Human Services. Office of Inspector General

Publisher

Department of Health and Human Services, Office of Inspector General

Pub. Date

2004.

Language

English

11) Medical equipment suppliers: compliance with Medicare standards

Author

United States. Department of Health and Human Services. Office of Inspector General

Publisher

Department of Health and Human Services, Office of Inspector General

Pub. Date

2001.

Language

English

12) New tools for curbing waste and fraud in Medicare and Medicaid: hearing before the Federal Financial Management, Government Information, Federal Services, and International Security Subcommittee of the Committee on Homeland Security and...

Author

Series

S. hrg volume 112-155

Publisher

U.S. G.P.O

Pub. Date

2011.

Language

English

13) States' collection of offset and supplemental Medicaid rebates

Author

United States. Department of Health and Human Services. Office of Inspector General

Publisher

Department of Health and Human Services, Office of Inspector General

Pub. Date

2014.

Language

English

14) Examining the administration's approval of Medicaid demonstration projects: hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, first session, June 24, 2015

Author

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health

Publisher

U.S. Government Publishing Office

Pub. Date

2015.

Language

English

15) Medicaid drug price comparisons: average sales price to average wholesale price

Author

United States. Department of Health and Human Services. Office of Inspector General

Publisher

Department of Health and Human Services, Office of Inspector General

Pub. Date

2005.

Language

English

16) Oversight of contract management at the Centers for Medicare and Medicaid Services: hearing before the Ad Hoc Subcommittee on Contracting Oversight of the Committee on Homeland Security and Governmental Affairs, United States Senate, One Hundred Eleventh...

Author

United States. Congress. Senate. Committee on Homeland Security and Governmental Affairs. Ad Hoc Subcommittee on Contracting Oversight

Series

S. hrg volume 111-739

Publisher

U.S. G.P.O

Pub. Date

2010.

Language

English

17) Comparison of Medicaid federal upper limit amounts to average manufacturer prices

Author

United States. Department of Health and Human Services. Office of Inspector General

Publisher

Department of Health and Human Services, Office of Inspector General

Pub. Date

2005.

Language

English

18) How inflated published prices affect drugs considered for the federal upper limit list

Author

United States. Department of Health and Human Services. Office of Inspector General

Publisher

Department of Health and Human Services, Office of Inspector General

Pub. Date

2005.

Language

English

19) Medicaid drug price comparisons: average manufacturer price to published prices

Author

United States. Department of Health and Human Services. Office of Inspector General

Publisher

Department of Health and Human Services, Office of Inspector General

Pub. Date

2005.

Language

English

20) CMS use of data on nursing home staffing: progress and opportunities to do more

Author

United States. Department of Health and Human Services. Office of Inspector General

Publisher

U.S. Department of Health and Human Services, Office of Inspector General

Pub. Date

2021.

Language

English

Didn't Find It?

Didn't find it in CW MARS? You can request titles from other Massachusetts library networks through the Commonwealth Catalog.
If you need assistance, please reach out to your local library.

Navigation

Main Navigation

Filter Results

Narrow Your Results

Catalog Search Results

1) Hearing on removing Social Security numbers from Medicare cards: joint hearing before the Subcommittee on Social Security and Subcommittee on Health of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Twelfth...

2) Full committee hearing on competitive bidding for clinical lab services: where it is heading and what small businesses can expect

3) Medicaid managed care encounter data: collection and use

4) Oversight challenges in the Medicare prescription drug program: hearing before the Federal Financial Management, Government Information, Federal Services, and International Security Subcommittee of the Committee on Homeland Security and...

5) The use of data to stop Medicare fraud: hearing before the Subcommittee on Oversight of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Fourteenth Congress, first session, March 24, 2015

6) Calculation of volume-weighted average sales price for Medicare Part B prescription drugs

7) CMS's implementation of safeguards during fiscal year 2006 to prevent and detect fraud and abuse in Medicare prescription drug plans

8) Medicare's program safeguard contractors: activities to detect and deter fraud and abuse

9) Roundtable discussion on Medicare physician payment policy: lessons from the private sector : hearing before the Committee on Finance, United States Senate, One Hundred Twelfth Congress, second session, June 14, 2012

10) Omission of drugs from the federal upper limit list in 2001

11) Medical equipment suppliers: compliance with Medicare standards

12) New tools for curbing waste and fraud in Medicare and Medicaid: hearing before the Federal Financial Management, Government Information, Federal Services, and International Security Subcommittee of the Committee on Homeland Security and...

13) States' collection of offset and supplemental Medicaid rebates

14) Examining the administration's approval of Medicaid demonstration projects: hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, first session, June 24, 2015

15) Medicaid drug price comparisons: average sales price to average wholesale price

16) Oversight of contract management at the Centers for Medicare and Medicaid Services: hearing before the Ad Hoc Subcommittee on Contracting Oversight of the Committee on Homeland Security and Governmental Affairs, United States Senate, One Hundred Eleventh...

17) Comparison of Medicaid federal upper limit amounts to average manufacturer prices

18) How inflated published prices affect drugs considered for the federal upper limit list

19) Medicaid drug price comparisons: average manufacturer price to published prices

20) CMS use of data on nursing home staffing: progress and opportunities to do more

Didn't Find It?